Viracta Therapeutics (VIRX)
NASDAQ:VIRX
Holding VIRX?
Track your performance easily

Viracta Therapeutics (VIRX) Ownership - Who Owns Viracta Therapeutics?

837 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 04, 2023
Mark Rothera
President & Ceo,director
xxxxxxxxxxxxx
$49000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,623,815Insider14.32%3,025,612
4,659,333Insider11.86%2,506,721
1,096,410Institution2.79%589,869
1,096,410Institution2.79%589,869
1,050,000Insider2.67%564,900
379,246Insider0.97%204,034
288,571Institution0.73%155,251
237,852Institution0.61%127,964
133,740Insider0.34%71,952
84,259Insider0.21%45,331

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,096,410Institution2.79%589,869
237,852Institution0.61%127,964
74,000Institution0.19%39,812
46,234Institution0.12%24,874
34,562Institution0.09%18,594
29,734Institution0.08%15,997
28,450Institution0.07%15,306
12,430Institution0.03%6,687
5,920Institution0.02%3,185
1,674Institution<0.01%901

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
813,922Institution2.07%569,745
282,488Institution0.72%197,742

FAQ

Who Owns Viracta Therapeutics (VIRX)?
Currently, no data Available
What percentage of Viracta Therapeutics (VIRX) stock is held by institutional investors?
Currently, no data Available
What percentage of Viracta Therapeutics (VIRX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Viracta Therapeutics (VIRX)?
Bay City Capital Llc owns the most shares of Viracta Therapeutics (VIRX).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis